2020
DOI: 10.4103/jfmpc.jfmpc_827_20
|View full text |Cite
|
Sign up to set email alerts
|

Palliative oral care in patients undergoing radiotherapy: Integrated review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(11 citation statements)
references
References 19 publications
0
10
0
1
Order By: Relevance
“…Radiotherapy combined, or not, with surgery and/or chemotherapy in order to treat head and neck cancers is possible [1,2]. Aforementioned, this therapy uses corpuscular or electromagnetic ionizing radiation that inhibits or undermines tumor cells [1]; however, this non-selective radiation may harm healthy cells and lead to systemic and oral detrimental effects [1,7]. Damage to salivary glands and mucositis have already been observed among patients who have received doses between 20 -30 Gy [8,9].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Radiotherapy combined, or not, with surgery and/or chemotherapy in order to treat head and neck cancers is possible [1,2]. Aforementioned, this therapy uses corpuscular or electromagnetic ionizing radiation that inhibits or undermines tumor cells [1]; however, this non-selective radiation may harm healthy cells and lead to systemic and oral detrimental effects [1,7]. Damage to salivary glands and mucositis have already been observed among patients who have received doses between 20 -30 Gy [8,9].…”
Section: Resultsmentioning
confidence: 99%
“…Head and neck radiotherapy may lead to both intense and tardily oral manifestations. Commonly observed, mucositis appears to be the most frequent acute effect after seven days [of treatment] [6,9]; in spite of, its intensity, duration, and chronology have been related to irradiation parameters and/or the cytotoxicity of drugs (in cases of combined chemotherapy) [7,9]. The irradiation causes cell death, inhibits the tissue recovery, and totally or partially exposes the oral mucosa [1,7]; in addition, multiple ulcerated fibrinous lesions covered by pseudomembranes, erythema, edema, pain, dysphagia, and nutrition deficiency might be observed [5,7].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…A xerostomia está diretamente ligada aos cuidados paliativos devido à prevalência nestes pacientes de neoplasias em Research, Society and Development, v. 10, n. 9, e52410918356, 2021 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v10i9.18356 regiões de cabeça e pescoço que carecem de tratamentos com radiação, ou em outros sítios do organismo que podem requerer tratamento quimioterápico que pode ocasionar muitos efeitos adversos. No caso de radioterapia em região de cabeça e pescoço, o mecanismo da hipossalivação e consequente xerostomia, ocorre já que o componente parenquimatoso das glândulas salivares é altamente sensível a radiação, a glândula torna-se fibrótica, reduzindo a microcirculação e ocorre uma degradação parenquimatosa, diminuindo então, o fluxo salivar (Sen, et. al 2020).…”
Section: Discussionunclassified
“…7 In people receiving palliative care, the prevalence of dry mouth increases due to polypharmacy, radiotherapy, and systemic conditions. [8][9][10][11] Prevalence of dry mouth in palliative populations varies greatly depending on which measures are used but several studies rate perceived dryness at over 70%. 3,7,12 In terms of prevalence, the National Institute for Health and Care Excellence (NICE) guidelines suggest a level as high as 88% in the terminally ill 13 and a more recent review article 14 reports that the level of xerostomia in end-of-life patients varied from 64-92%.…”
Section: Introductionmentioning
confidence: 99%